Chers amis gastro, nous avons besoin de vous ! Le GETAID lance ICARE II ▶️évaluer en vie réelle la tolérance des nouveaux traitements des MICI ▶️ Tous les gastroentérologues en France peuvent participer ✅ Concept du patient chercheur Inscription lien ou MP

See you soon at #UEGW for the SciCom Meeting #ICARE at Copenhague : Saturday 15th October.

🚨 GETAID at #UEGWeek 🚨 #BCaron presenting the CURE prospective study. 50% of CD patients still in deep remission 1 year after adalimumab withdrawal in patients with early CD. Laurent Peyrin-Biroulet Mathurin Fumery

🚨 GETAID at #UEGWeek 🚨 Mathieu Uzzan presenting the #TOFAPRO study. 35 patients with refractory ulcerative #proctitis treated with tofa 40% in clinical steroid-free remission at induction. Largest rwe of tofa for #proctitis

jeremielefevre presenting the GETAID Crohn’s disease post operative cohort : no protective effect of the Kono-S method. Randomised controlled study is ongoing #UEGWeek2023 Hôpital Saint-Antoine AP-HP Faculté de Santé de Sorbonne Université

Our ⭐️ Mathurin Fumery shining at #UEGWeek2023 with a GETAID Study about biologics and risk of early post operative complications. Congrats 🎉 for the prize!!

A RCT in ASUC by GETAID ! Combo vs Mono-AZA in patients with #ASUC who responded to steroids. Great presentation by prof. Amiot

We are thrilled to announce the publication in Journal of Crohn's and Colitis of 🇫🇷 nationwide study by GETAID Surgery Group, comparing the effectiveness of KONO-S versus conventional anastomosis in CD. academic.oup.com/ecco-jcc/artic… jeremielefevre Steven D Wexner MD, PhD Antonino Spinelli Beatriz Gros

Informative collaborative study between GETAID and LYSA. "Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa" pubmed.ncbi.nlm.nih.gov/37850555/

The new GETAID adventure #icare2

Le GETAID présent a l’AFEMI pour la journée nationale d’éducation thérapeutique dans les MICI #ETP #empowerment

C. Reenaers presenting histologic data of the STORI trial 👏 👏

Enfin ! Une superbe avancée pour nos patients! Écoutez notre président D. Laharie a ce sujet.

Ils parlent de nous… 👀 Merci à la La Gazette du LABORATOIRE pour son article sur le GETAID ! 🔎👩🏻⚕️

5 Nations is going to start…. Looking forward to be in Porto and start one of the best IBD advanced courses for young IBD fellows. GEDII IGIBD GETECCU GETAID #israeliIBDsociety

The first day of 5 Nations ended with a bang! A taste of port wine on a cellar and a rooftop dinner! Today the work continues with discussions about topics like IBD diagnosis, ultrasound or disease monitoring 💪💪💪#5NationsMeetinginIBD

❤️

En effet. Merci Laurent!

Le Séminaire GETAID-REMIND aura lieu le jeudi 5 décembre et le vendredi 6 décembre 2024 ! 🎉 Les inscriptions sont ouvertes 😃

Les inscriptions pour la Masterclass du GETAID sont lancées ! 🥳 Au programme : mises au point, échanges avec les experts, ateliers,... Le programme complet disponible ici : getaid.org/actualites/mas…